US Patent Issued to The Regents of the University of Michigan, The University of Mississippi Medical Center on Nov. 25 for "Serum metabolites as biomarkers for carnitine treatment of sepsis" (Mississippi, Michigan Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,603, issued on Nov. 25, was assigned to The Regents of the University of Michigan (Ann Arbor, Mich.) and The University of Mississippi Medical Center (Jackson, Miss.).

"Serum metabolites as biomarkers for carnitine treatment of sepsis" was invented by Michael A. Puskarich (Jackson, Miss.), Alan E. Jones (Jackson, Miss.), Christopher E. Gillies (Ann Arbor, Mich.), Theodore S. Jennaro (Ann Arbor, Mich.) and Kathleen A. Stringer (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is technology relating to treating septic shock and particularly, but not exclusively, to methods and systems for identifying sepsis patients most...